CHARACTERIZING THE MANAGEMENT OF PATIENTS WITH NASH (WITH VERSUS WITHOUT CIRRHOSIS) IN REAL-WORLD CLINICAL PRACTICE: RARE ASSESSMENT BY HEPATOLOGISTS AND LOW FREQUENCY OF IMAGING

被引:0
|
作者
Qian, Christina [1 ]
Charlton, Michael R. [2 ]
Szabo, Shelagh M. [1 ]
Sun, Rosie [1 ]
Rochon, Hannah [1 ]
Fishman, Jesse [3 ]
机构
[1] Broadstreet Heor, Vancouver, BC, Canada
[2] Univ Chicago, Chicago, IL USA
[3] Madrigal Pharmaceut, W Conshohocken, PA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2149-A
引用
收藏
页码:S927 / S928
页数:2
相关论文
共 50 条
  • [41] Management of patients with Dravet syndrome in real-world clinical practice across five countries in Europe: Impact of treatment-related burden on health outcomes
    Ross, E.
    Shah, D.
    Biedermann, P.
    Taylor, Y.
    Villanueva, V.
    Benitez, A.
    Berthoz, F. Truong
    Lai, S.
    Andrews, J. S.
    EPILEPSIA, 2024, 65 : 169 - 169
  • [42] Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting
    Fox, Kathleen M.
    Gandhi, Sanjay K.
    Ohsfeldt, Robert L.
    Davidson, Michael H.
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (10): : S270 - S275
  • [43] Real-world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK-based electronic health records database
    Seesaghur, Anouchka
    Petruski-Ivleva, Natalia
    Banks, Victoria
    Wang, Jocelyn Ruoyi
    Mattox, Pattra
    Hoeben, Edwin
    Maskell, Joe
    Neasham, David
    Reynolds, Shannon L.
    Kafatos, George
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (02) : 248 - 256
  • [44] Frequency and management of trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV)-associated neutropenia in patients with refractory metastatic colorectal cancer (mCRC) in real-world practice
    Lago, N. Martinez
    Rendo, C. Reboredo
    Chucla, T. Calleja
    Salvador, M. Mateos
    Fernandez, F. Busto
    Gomez, J. de la Camara
    Reboredo-Lopez, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S100 - S101
  • [45] Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?
    Parkin, Lianne
    Williams, Sheila
    Barson, David
    Sharples, Katrina
    Horsburgh, Simon
    Jackson, Rod
    Dummer, Jack
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [46] Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice
    Delforge, Michel
    Vekemans, Marie-Christiane
    Depaus, Julien
    Meuleman, Nathalie
    Van de Velde, Ann
    Vande Broek, Isabelle
    Vandervennet, Sophie
    Van Hoorenbeeck, Sandra
    Moorkens, Evelien
    Strens, Danielle
    Diels, Joris
    Ghilotti, Francesca
    Haefliger, Benjamin
    Dalhuisen, Sander
    Deraedt, William
    Anguille, Sebastien
    HEMASPHERE, 2022, 6 (12):
  • [47] Similar clinical outcomes for natalizumab patients switching to every-6-week dosing versus remaining on every-4-week dosing in real-world practice
    Butzkueven, H.
    Kappos, L.
    Spelman, T.
    Trojano, M.
    Wiendl, H.
    Su, R.
    Hyde, R.
    Licata, S.
    Ho, P. -R.
    Campbell, N.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 308 - 308
  • [48] Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma
    Moreau, Philippe
    van de Donk, Niels W. C. J.
    Delforge, Michel
    Einsele, Hermann
    De Stefano, Valerio
    Perrot, Aurore
    Besemer, Britta
    Pawlyn, Charlotte
    Karlin, Lionel
    Manier, Salomon
    Leleu, Xavier
    Weisel, Katja
    Ghilotti, Francesca
    Diels, Joris
    Elsada, Ahmed
    Morano, Raul
    Strulev, Vadim
    Pei, Lixia
    Kobos, Rachel
    Smit, Jennifer
    Slavcev, Mary
    Mateos, Maria-Victoria
    ADVANCES IN THERAPY, 2023, 40 (05) : 2412 - 2425
  • [49] Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma
    Philippe Moreau
    Niels W. C. J. van de Donk
    Michel Delforge
    Hermann Einsele
    Valerio De Stefano
    Aurore Perrot
    Britta Besemer
    Charlotte Pawlyn
    Lionel Karlin
    Salomon Manier
    Xavier Leleu
    Katja Weisel
    Francesca Ghilotti
    Joris Diels
    Ahmed Elsada
    Raul Morano
    Vadim Strulev
    Lixia Pei
    Rachel Kobos
    Jennifer Smit
    Mary Slavcev
    Maria-Victoria Mateos
    Advances in Therapy, 2023, 40 : 2412 - 2425
  • [50] Comparative Assessment of Clinical Outcomes Between Abiraterone Acetate and Enzalutamide in Patients With Docetaxel-Naive Metastatic Castration-Resistant Prostate Cancer: Experience in Real-World Clinical Practice in Japan
    Miyake, Hideaki
    Hara, Takuto
    Terakawa, Tomoaki
    Ozono, Seiichiro
    Fujisawa, Masato
    CLINICAL GENITOURINARY CANCER, 2017, 15 (02) : 313 - 319